Similar Items: Population pharmacokinetic modelling for dose optimization of esomeprazole to treat early-onset preeclampsia
- Population pharmacokinetics and pharmacokinetic-pharmacodyamic modeling of antitubercular drugs
- The pharmacokinetics of lopinavir in HIV-infected adults receiving rifampicin with adjusted doses of lopinavir
- Population pharmacokinetic and pharmacodynamic modelling to improve tuberculosis treatment
- Population pharmacokinetic modelling to address the gaps in knowledge of commonly used HIV and TB drugs in children
- The Preeclampsia intervention with Esomeprazole (PIE) trial: A double blind, randomised, placebo-controlled trial to treat early onset severe preeclampsia
- Characterizing population pharmacokinetic/pharmacodynamic relationships in pulmonary tuberculosis infected adults using nonlinear mixed effects modelling